082800 — Vivozon Pharmaceutical Co Cashflow Statement
0.000.00%
- KR₩152bn
- KR₩183bn
- KR₩71bn
- 26
- 38
- 26
- 16
Annual cashflow statement for Vivozon Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -22,639 | -44,085 | -71,015 | -39,234 | -3,357 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 11,265 | 39,472 | 56,407 | 27,559 | 7,213 |
Discontinued Operations | |||||
Unusual Items | |||||
Purchased R&D | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -12,105 | 7,058 | -8,441 | 4,708 | -4,092 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -21,361 | 4,625 | -17,496 | -3,323 | 2,992 |
Capital Expenditures | -337 | -1,197 | -12,281 | -8,643 | -6,670 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -35,296 | -62,987 | -34,847 | -25,909 | 25,979 |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Sale of Intangible Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -35,633 | -64,184 | -47,128 | -34,552 | 19,309 |
Financing Cash Flow Items | 23,490 | -1,800 | -2,075 | -4,503 | -1,476 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 102,074 | 67,235 | 13,515 | 26,391 | -16,659 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 45,014 | 7,000 | -50,533 | -11,448 | 5,635 |